|本期目录/Table of Contents|

[1]苏兆铎,郭书文,张璐,等.调脂通脉方对动脉粥样硬化兔模型血管重塑的影响[J].环球中医药,2017,10(04):430-435.[doi:10.3969/j.issn.1674-1749.2017.04.011]
 SU Zhaoduo,GUO Shuwen,ZHANG Lu,et al.Influences of Tiaozhi Tongmai formula on vascular remodeling in rabbits with atherosclerosis[J].,2017,10(04):430-435.[doi:10.3969/j.issn.1674-1749.2017.04.011]
点击复制

调脂通脉方对动脉粥样硬化兔模型血管重塑的影响()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第10卷
期数:
2017年04期
页码:
430-435
栏目:
论著
出版日期:
2017-04-06

文章信息/Info

Title:
Influences of Tiaozhi Tongmai formula on vascular remodeling in rabbits with atherosclerosis
作者:
苏兆铎郭书文张璐马卉郑敏武建功吴佳妮陈曦刘文臣马如风
100029 北京中医药大学基础医学院[苏兆铎(硕士研究生)、郭书文、张璐、武建功、吴佳妮、陈曦、刘文臣、马如风]; 北京中医药大学东直门医院皮肤科(马卉); 中日友好医院超声诊断科(郑敏)
Author(s):
SU ZhaoduoGUO ShuwenZHANG Luet al.
Beijing University of Chinese Medicine, Beijing 100029,China
关键词:
调脂通脉中药 动脉粥样硬化 血管重塑
Keywords:
Tiaozhi Tongmai formula Atherosclerosis Vascular remodeling
分类号:
R972+.6
DOI:
10.3969/j.issn.1674-1749.2017.04.011
文献标志码:
A
摘要:
目的 探讨调脂通脉方对动脉粥样硬化兔模型血管重塑相关影响因素的调控机制。方法 通过高脂饲料饮食及球囊损伤术建立动脉粥样硬化兔模型,54只兔随机分成5组,正常组、模型组、假手术组、阿托伐他汀组(2.2 mg/kg)和调脂通脉方组(8 g/kg); 除正常组外,其余四组选择45天、90天两个观察点,45天时观察动物30只,90天时观察动物24只。对各组兔模型左颈总动脉的管腔内径、内中膜厚度和收缩期峰值流速采用超声测量; 对颈总动脉作病理学观察; 采用酶联免疫吸附测定法检测血清MMP-1、MMP-2、TIMP-1、PD-ECGF、UA水平。结果 两个时间点,模型组兔血清中MMP-1、MMP-2、PD-ECGF、UA表达水平明显高于假手术组(P<0.01),TIMP-1低于假手术组(P<0.01)。调脂通脉方组家兔血清MMP-1、MMP-2、PD-ECGF、UA水平较模型组明显下降(P<0.01),TIMP-1水平明显升高(P<0.01),与阿托伐他汀组无明显差异。结论 调脂通脉方降低了MMP-1、MMP-2、PD-ECGF、UA水平,提高了TIMP-1水平,从而影响动脉粥样硬化的血管重塑,进而改善动脉粥样硬化,可能是其作用机制。
Abstract:
Objective To investigate the regulatory mechanism of Tiaozhi Tongmai formula on vascular remodeling related factors in rabbits with atherosclerosis. Method The rabbit model of atherosclerosis was established by high fat diet and balloon injury. 54 rabbits were randomly divided into normal group, model group, sham operation group, atorvastatin group and Chinese medicine group. Except the rabbits in normal group, the remaining four groups to choose the observation point at 45 day and 90 day after treatment. At 45 days, 30 animals were observed. At 90 days, 24 animals were observed. The lumen diameter and the intima-media thickness and the peak systolic velocity was measured by ultrasound. The common carotid arteries were observed by pathology. The levels of matrix metalloproteinases(MMP-1, MMP-2), tissue inhibitor of metalloproteinase-1(TIMP-1), platelet derived endothelial cell growth factor(PD-ECGF)and uric acid was detected by enzyme-linked immunosorbent assay(ELISA). Result There are two time points, the expression levels of MMP-1, MMP-2, PD-ECGF and UA in the model group were significantly higher than those in the sham operation group(P<0.01), TIMP-1 was lower than that in sham operation group(P<0.01). The serum levels of MMP-1, MMP-2, PD-ECGF and UA in the Tiaozhi Tongma formula group was significantly lower than those in the model group(P<0.01), the level of TIMP-1 was significantly increased(P<0.01), there was no significant difference from atorvastatin group. Conclusions Tiaozhi Tongmai formula can reduced the level of MMP-1, MMP-2,PD-ECGF, UA, and increase the level of TIMP-1, therefore influence the vascular remodeling to improve atherosclerosis, this may be the mechanism of its.

参考文献/References:

[1] 李艳艳.兔动脉粥样硬化的炎症—血管重塑机制探讨[D].天津:天津医科大学,2013.
[2] 谭蓓,关玉庆,孙慧,等.血管内超声检测阿托伐他汀对兔动脉粥样硬化斑块的影响[J].山东大学学报(医学版),2015,(5):10-14,20.
[3] 孙晴.动脉粥样硬化脂质斑块形成评估及调脂通脉颗粒作用机制研究[D].北京:北京中医药大学,2014.
[4] Katja Lakota, Mrak-Poljsak K, Blaz Rozman, et al.Increased Responsiveness of Human Coronary Artery Endothelial Cells in Inflammation and Coagulation[J]. Mediators of Inflammation,2009,2009(1):75-79(1-5).
[5] Bai X; Wang X; Xu Q. Endothelial damage and stem cell repair in atherosclerosis[J]. Vascular Pharmacology,2010,52(5-6):224-229.
[6] R Liu,W Wu,L Chen,et al.Transcriptional expression profiles of the main proteinases and their regulators in coronary artery ectasia patients' mononuclear cells[J].Acta Cardiol, 2016,71(2):157-163.
[7] E.Hopps,G. Caimi.Matrix metalloproteases as a pharmacological target in cardiovascular diseases[J]. European Review for Medical and Pharmacological Sciences,2015,19(14):2583-2589.
[8] Li W,Gigante A, Perez-perez MJ, et al.Thymidine phosphorylase participates in platelet signaling and promotes thrombosis[J]. Circulation Research,2014,115(12):997-1006.
[9] Gur M, Sahin DY, Elbasan Z, et al.Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis[J].Journal of Cardiology,2013,61(2):144-148.
[10] 冯斌,杨庭树,张华巍.高脂饲料喂养与动脉内膜球囊损伤结合建立兔腹主动脉粥样硬化模型[J].中国组织工程研究与临床康复,2009,13(15):2911-2914.
[11] 黄爱良,黄荣志,黄小倩,等.动脉粥样硬化动物模型构建的方法与现状[J].中国组织工程研究,2015,(27):4423-4428.
[12] 刘洋,何春水.兔动脉粥样硬化改良模型的建立及其评价[J].泸州医学院学报,2015,(4):408-412.
[13] 周培娟,王乐,王爱成,等.针刺治疗下肢动脉硬化闭塞症取穴规律分析[J].河南中医,2015,35(3):620-622.
[14] 曾国安,陈玉燕,李博,等.黄芪多糖对兔动脉粥样硬化内皮细胞功能的影响[J].中西医结合心脑血管病杂志,2010,8(10):1206-1208.
[15] Hsin-Hung Lin, Albert Linton Charles, Chang-Wei Hsieh, et al. Antioxidant effects of 14 Chinese traditional medicinal herbs against human low-density lipoprotein oxidation[J]. Journal of Traditional and Complementary Medicine,2015,5(1):51-55.
[16] 赵文萃,张宁,周慧琴,等.三七总黄酮对高血脂大鼠血脂的影响[J].中国实验方剂学杂志,2016,(8):143-147.
[17] 武金霞,武建,隋思强,等.蚯蚓冻干粉对高血脂小鼠胆固醇逆转运相关基因的调节作用[J].河北大学学报(自然科学版),2015,35(2):159-164.
[18] 张建永.丹参山楂组分配伍抗动脉粥样硬化及作用机制研究[D].北京:中国中医科学院,2013.
[19] 陈兴娟,尹萌萌,魏建梁,等.泽泻在心血管疾病治疗中的应用[J].长春中医药大学学报,2014,30(4):620-622.
[20] Lee YC, Chuah AM, Yamaguchi T,et al.Antioxidant activity of traditional Chinese medicinal herbal materials[J].Food Sci Technol Res,2008,4(4):205-210.

相似文献/References:

[1]李静,彭宁,刘勤社,等.活血胶囊对动脉粥样硬化兔平滑肌细胞凋亡及Bcl-2、Bax蛋白表达的影响[J].环球中医药,2012,5(07):506.
 LI Jing,PENG Ning,LIU Qin-she,et al.Effect of Huoxue Capsule on the apoptosis of vascular smooth muscle cell and expression of Bcl-2 and Bax protein on rabbits with atherosclerosis[J].,2012,5(04):506.
[2]李贞玉,杨惠民,郭杨志,等.血脂异常患者中医证型及血清sICAM-1、sVCAM-1水平与幽门螺旋杆菌感染的相关性研究[J].环球中医药,2015,8(02):137.[doi:10.3969/j.issn.1674-1749.2015.02.003]
 LI Zhen-yu,YANG Hui-min,GUO Yang-zhi,et al.Correlation study between the TCM syndromes of dyslipidemia, the level of serum sICAM-1,sVCAM-1 and helicobacter pylori infection[J].,2015,8(04):137.[doi:10.3969/j.issn.1674-1749.2015.02.003]
[3]杨祎,司晓雪,邵楚茜,等.健脾祛痰化瘀法防治动脉粥样硬化的临床研究进展[J].环球中医药,2015,8(09):1130.[doi:10.3969/j.issn.1674-1749.2015.09.030]
 YANG Yi,SI Xiao-xue,SHAO Chu-qian,et al.Advances in the clinical researches of treating atherosclerosis via the method of invigorating spleen, removing phlegm and eliminating blood statisis[J].,2015,8(04):1130.[doi:10.3969/j.issn.1674-1749.2015.09.030]
[4]郝蔷薇,麻春杰,乌兰其其格,等.额尔敦—乌日勒对动脉粥样硬化家兔血管内皮因子内皮素、血小板活化因子的影响[J].环球中医药,2015,8(12):1433.[doi:10.3969/j.issn.1674.1749.2015.12.003]
 HAO Qiang-wei,MA Chun-jie,WUlAN Qi-qige,et al.Research on the effect of Eerdun-wurili on rabbit atherosclerotic vulnerable plaque endothelial function[J].,2015,8(04):1433.[doi:10.3969/j.issn.1674.1749.2015.12.003]
[5]武迎磊 赵天 李明.灯盏花素对大鼠动脉粥样硬化保护作用的研究[J].环球中医药,2017,10(06):569.[doi:10.3969/j.issn.1674-1749.2017.06.007]
 WU Yinglei,ZHAO Tian,LI Ming..Protective effects and mechanism of breviscapine on atherosclerosis rats[J].,2017,10(04):569.[doi:10.3969/j.issn.1674-1749.2017.06.007]
[6]于少泓.马黛通络饮对APOE基因敲除小鼠脂质代谢的影响[J].环球中医药,2017,10(09):957.[doi:10.3969/j.issn.1674-1749.2017.09.006]
 YU Shaohong..Effects of Madai Tongluo decoction on lipid metabolism in apolipoprotein E-deficient mice[J].,2017,10(04):957.[doi:10.3969/j.issn.1674-1749.2017.09.006]

备注/Memo

备注/Memo:
基金项目: 国家国际科技合作专项(2011DFA33040)
作者简介:苏兆铎(1990- ),2014级在读硕士研究生。研究方向:中西医结合防治心血管疾病。E-mail:suzhaoduo@126.com
通信作者:郭书文(1965- ),博士,教授,博士生导师。研究方向:中西医结合防治心血管疾病。E-mail:guo1163@163.com
更新日期/Last Update: 2017-04-06